SCHEMBL201657

SCHEMBL201657

CC(C)(CN1CCOCC1)Sc1ccc(O)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.40
ALOX15 P16050 2/20 0.39
CYP2C9 P11712 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.38
MAPK1 P28482 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
POLB P06746 1/20 0.37
FKBP1A P62942 2/20 0.36
GAA P10253 2/20 0.36
LMNA P02545 2/20 0.36
SIGMAR1 Q99720 1/20 0.35
TP53 P04637 1/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL201656 0.85 GAA (0.39) ALOX15SMN1; SMN2MAPK1ALDH1A1TSHR
SCHEMBL201588 0.76 SHBG (0.46) ATMALOX15CYP2C9HSD17B10SMN1; SMN2
SCHEMBL8746050 0.74 HSD17B10 (0.50) ATMALOX15CYP2C9HSD17B10SMN1; SMN2
SCHEMBL872596 0.70 ALDH1A1 (0.38) ALOX15HSD17B10SMN1; SMN2ALDH1A1TSHR
SCHEMBL11478965 0.70 POLB (0.56) ATMHSD17B10SMN1; SMN2ALDH1A1POLB
SCHEMBL202011 0.69 ESR1 (0.45) ALOX15CYP2C9HSD17B10SMN1; SMN2MAPK1
SCHEMBL23329659 0.69 AOC2 (0.59) ATMALDH1A1POLBGAALMNA
SCHEMBL11458534 0.69 ALDH1A1 (0.42) ATMALOX15CYP2C9HSD17B10SMN1; SMN2
SCHEMBL11458522 0.68 POLB (0.65) ATMHSD17B10MAPK1ALDH1A1POLB
SCHEMBL22020962 0.68 ALDH1A1 (0.36) ALOX15HSD17B10SMN1; SMN2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088922-B2 Dibenzorylenetetracarboximides as infrared absorbers BASF AKTIENGESELLSCHAFT (DE) 2012-01-03 US disclosed
EP-2029573-B1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2011-10-26 EP disclosed
US-20100048904-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF AKTIENGESELLSCHAFT (DE) 2010-02-25 US disclosed
EP-2029573-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2009-03-04 EP disclosed
WO-2007138051-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048904-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS TDO2, C9, CYP3A43 ATM 4045/4885ALOX15 101/4885CYP2C9 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.